Evaluating tuberculosis treatment outcomes in Haiti from 2018 to 2019: A competing risk analysis.
IJID Reg
; 11: 100350, 2024 Jun.
Article
em En
| MEDLINE
| ID: mdl-38577553
ABSTRACT
Objectives:
This study assesses tuberculosis (TB) treatment outcomes in Haiti.Methods:
Data from drug-susceptible patients with TB (2018-2019) were analyzed using the Fine & Gray model with multiple imputation.Results:
Of the 16,545 patients, 14.7% had concurrent HIV coinfection, with a 66.2% success rate. The median treatment duration was 5 months, with patients averaging 30 years (with an interquartile range of 22-42 years). The estimated hazard of achieving a successful treatment outcome decreased by 2.5% and 8.1% for patients aged 45 and 60 years, respectively, compared with patients aged 30 years. Male patients had a 6.5% lower estimated hazard of success than their female counterparts. In addition, patients coinfected with HIV experienced a 35.3% reduction in the estimated hazard of achieving a successful treatment outcome compared with those with a negative HIV serologic status.Conclusions:
Integrated health care approaches should be implemented, incorporating innovative solutions, such as machine learning algorithms combined with geographic information systems and non-conventional data sources (including social media), to identify TB hotspots and high-burden households.
Texto completo:
1
Bases de dados:
MEDLINE
País/Região como assunto:
Haiti
Idioma:
En
Revista:
IJID Reg
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Suíça